These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31582682)

  • 1. Peripheral polyneuropathy in patients receiving long-term statin therapy.
    Özdemir IH; Copkiran Ö; Tıkız H; Tıkız C
    Turk Kardiyol Dern Ars; 2019 Oct; 47(7):554-563. PubMed ID: 31582682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of statin induced reduction in serum coenzyme Q10 level and conduction deficits in motor and sensory nerves: An observational cross-sectional study.
    Gurha N; Rehan HS; Yadav M; Gupta LK
    Clin Neurol Neurosurg; 2020 Sep; 196():106046. PubMed ID: 32634700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of High-Intensity Statins in the Veteran Population: Atorvastatin 40 to 80 mg Compared With Rosuvastatin 20 to 40 mg.
    Stein B; Ward T; Hale G; Lyver E
    Ann Pharmacother; 2020 May; 54(5):405-413. PubMed ID: 31718234
    [No Abstract]   [Full Text] [Related]  

  • 4. LDL cholesterol levels after switch from atorvastatin to rosuvastatin.
    Lewis SJ; Olufade T; Anzalone DA; Malangone-Monaco E; Evans KA; Johnston S
    Curr Med Res Opin; 2018 Oct; 34(10):1717-1723. PubMed ID: 29271267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus.
    Giustino G; Colantonio LD; Brown TM; Carson AP; Dai Y; Farkouh ME; Monda KL; Muntner P; Rosenson RS
    Cardiovasc Drugs Ther; 2018 Oct; 32(5):453-461. PubMed ID: 30078077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of rosuvastatin and atorvastatin on erectile dysfunction in hypercholesterolaemic patients.
    Nurkalem Z; Yildirimtürk Ö; Özcan KS; Kul Ş; Çanga Y; Satılmış S; Bozbeyoğlu E; Kaya C
    Kardiol Pol; 2014; 72(3):275-9. PubMed ID: 24142756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use and peripheral nerve function-A prospective follow-up study.
    Svendsen TK; Krøigård T; Wirenfeldt M; Schrøder HD; Bak S; Möller S; Hallas J; Sindrup SH; Gaist D
    Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):203-211. PubMed ID: 31505101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins an oft-prescribed drug is implicated in peripheral neuropathy: The time to know more.
    Al-Kuraishy HM; Al-Gareeb AI; Hussien NR; Al-Naimi MS; Rasheed HA
    J Pak Med Assoc; 2019 Aug; 69(Suppl 3)(8):S108-S112. PubMed ID: 31603889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase.
    Gupta A; Thompson D; Whitehouse A; Collier T; Dahlof B; Poulter N; Collins R; Sever P;
    Lancet; 2017 Jun; 389(10088):2473-2481. PubMed ID: 28476288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA-reductase inhibitors and neuropathy: reports to the Netherlands Pharmacovigilance Centre.
    de Langen JJ; van Puijenbroek EP
    Neth J Med; 2006 Oct; 64(9):334-8. PubMed ID: 17057271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial.
    Obońska K; Kasprzak M; Sikora J; Obońska E; Racki K; Goździkiewicz N; Krintus M; Kubica J
    Trials; 2017 Jul; 18(1):316. PubMed ID: 28697767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Efficacy of Statins for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease: A Network Meta-Analysis.
    Zhou X; Dai J; Xu X; Wang Z; Xu H; Chen J; Qiu Y; Mao W
    Angiology; 2019 Apr; 70(4):305-316. PubMed ID: 30261736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
    Robinson JG; Nedergaard BS; Rogers WJ; Fialkow J; Neutel JM; Ramstad D; Somaratne R; Legg JC; Nelson P; Scott R; Wasserman SM; Weiss R;
    JAMA; 2014 May; 311(18):1870-82. PubMed ID: 24825642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.
    Kang J; Kim YC; Park JJ; Kim S; Kang SH; Cho YJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Chae IH; Choi DJ
    Cardiovasc Diabetol; 2018 Jan; 17(1):10. PubMed ID: 29325562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
    Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K
    Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with statins and peripheral neuropathy: results of 36-months a prospective clinical and neurophysiological follow-up.
    Otruba P; Kanovsky P; Hlustik P
    Neuro Endocrinol Lett; 2011; 32(5):688-90. PubMed ID: 22167150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications of Switching Lipid Lowering Treatment from Rosuvastatin to Other Agents in Primary Care.
    Colivicchi F; Gulizia MM; Franzini L; Imperoli G; Castello L; Aiello A; Ripellino C; Cataldo N
    Adv Ther; 2016 Nov; 33(11):2049-2058. PubMed ID: 27671328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects.
    Ramakumari N; Indumathi B; Katkam SK; Kutala VK
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S120-S125. PubMed ID: 30595243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of HMG-CoA reductase inhibitors with neuropathy.
    Backes JM; Howard PA
    Ann Pharmacother; 2003 Feb; 37(2):274-8. PubMed ID: 12549960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.